News
PMCPA News
Press releases appear below, filter by date.
ABPI Code Of Practice training
Press release: 17 January 2024
ABPI Code Of Practice training
Vacancy for the position of Deputy Director, PMCPA
Press release: 22 March 2024
Vacancy for the position of Deputy Director, PMCPA
Teva and Daiichi Sankyo named in advertisements for breaches of the ABPI Code
Press release: 27 March 2024
Teva and Daiichi Sankyo named in advertisements for breaches of the ABPI Code
Consultation on proposed changes to the 2021 ABPI Code and PMCPA Constitution and Procedure - Update
Press release: 13 June 2024
Consultation on proposed changes to the 2021 ABPI Code and PMCPA Constitution and Procedure - Update
New webform for companies to submit nominated signatories
Press release: 20 June 2024
ABPI Code of Practice training
Press release: 02 July 2024
Novartis, Pfizer, Otsuka and Novo Nordisk named in advertisements for breaches of the ABPI Code
Press release: 05 July 2024
PMCPA Annual Report 2022 and 2023
Press release: 09 September 2024
New Appointments at the PMCPA
Press release: 09 September 2024
2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA
Press release: 23 September 2024
2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA
Documents outlining the changes to the ABPI Code (Updated)
Press release: 01 October 2024
Webinars on changes in 2024 Code and an interactive e-learning module have been published
Press release: 10 October 2024
Three ‘On demand’ webinars explaining the changes in the 2024 ABPI Code are now available free of charge on the new dedicated learning portal for the Prescription Medicines Code of Practice Authority (PMCPA).
An interactive e-learning module targeted at individuals requiring an overview of the ABPI Code has now also been launched on the learning portal.